Anacor Pharmaceuticals, Inc. v. Lupin Limited

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE IN RE KERYDIN (TAVABOROLE) TOPICAL SOLUTION 5% PATENT LITIGATION MDL No. 19-md-2884-RGA ANACOR PHARMACEUTICALS, INC., Plaintiff, v. C.A. No. 18-1606-RGA LUPIN LIMITED, et al., Defendants. REPORT AND RECOMMENDATION1 Pending before the Court is Defendant FlatWing Pharmaceuticals, LLC’s (“FlatWing’s”) Motion for Fees pursuant to 35 U.S.C. § 285. (No. 18-1606-RGA, D.I. 98; No. 19-md-2884-RGA, D.I. 79.)2 For the reasons stated in more detail below, I recommend that the Court DENY the motion. I. BACKGROUND This is an ANDA case.…